Enliven Therapeutics

Drug Discovery · Biotechnology
Listed: NASDAQ: ELVN2 legal entities

Facts

as of Nov 17, 2026

We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and better.

Legal name
Enliven Therapeutics, Inc.
Headquarters
Boulder, United States
Founded
2016
Employees
201-500estimated range
Legal entities
2 in 1 countries
Listing
NASDAQ: ELVN
Register numbers
NAME enliven therapeutics inc
Official records
SEC CIK 1672619
Website
enliventherapeutics.com

These are the key facts about Enliven Therapeutics on Alion as of Nov 17, 2026. Enliven Therapeutics is headquartered in Boulder, United States. It was founded in 2016. It has raised $140.1M in 3 funding rounds. The latest round is Venture - Series Unknown of $90M, announced in 2024.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Enliven Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 2 cities in 1 country.

2Cities
1Countries
Loading the map
SiteTypeOpen rolesHires most forEngineering
Boulder United StatesHeadquarters0
Burlingame United StatesRegional office0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$140.1MTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2024$90M1 record
2019$44.1M1 record
2016$6M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Mar 21, 2024
Mar 15, 2019
2016
Founded
Each milestone is dated by its source: registers, filings, the press